Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative

Hunt, Nicholas B. and Emmens, Johanna E. and Irawati, Sylvi and de Vos, Stijn and Bos, Jens H.J. and Wilffert, Bob and Hak, Eelko and de Boer, Rudolf A. (2022) Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative. Medicine, 101 (2). p. 28394. ISSN 1536-5964

[thumbnail of Sylvi Irawati_Sex_disparities_in_the_effect_of_statins_on_lipid.8.pdf] PDF
Sylvi Irawati_Sex_disparities_in_the_effect_of_statins_on_lipid.8.pdf

Download (721kB)
Official URL / DOI:


Real-world evidence on a potential statin effect modification by sex is inconclusive, especially for the primary prevention of cardiovascular disease (CVD). We aimed to quantify the differences in the effect of statins on lipid parameters between men and women. The PharmLines Initiative linked the Lifelines Cohort Study and the prescription database. This database covers a representative population from the Netherlands. We selected participants aged ≥40 years at the index date: the date of the first prescription of any statin monotherapy in the study period 2006 to 2017. Multivariate regression modeling was used to compare the difference of the mean percentage change of lipid parameters (% mean difference [MD]) from baseline to follow-up measurement between the sexes. Out of 5366 statin users from approximately 50,000 participants available in the final linked database, 685 were statin initiators. At baseline, women had significantly higher levels of mean total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) than men (all P values <.01). At follow-up, women had a significantly higher mean percentage change of HDL-C compared to men (adjusted % MD 5.59, 95% confidence interval [CI] 2.42-8.75, P < .01). There was no significant sex difference in other parameters, nor in the proportion of men and women who achieved LDL-C ≤2.5 mmol/L. Statins appear to have a greater effect on increasing HDL-C levels in women than men while showing similar effect on other lipid parameters in both sexes. Men should not be treated differently than women.

Item Type: Article
Uncontrolled Keywords: drug prescriptions, lipids, medical record linkage, pharmacoepidemiology, sex, statins, treatment outcome
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Pharmacy > Department of Pharmacy
Depositing User: Sylvi Irawati, M.Farm., Apt. 208004
Date Deposited: 07 Jun 2022 08:40
Last Modified: 07 Jun 2022 08:40

Actions (login required)

View Item View Item